Advertisement

Uterine Cancer pp 175-192 | Cite as

Early-Stage Endometrial Cancer

Radiation
  • Lea BaerEmail author
  • A. Gabriella Wernicke
  • Silvia Formenti
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

Radiotherapy has been used as an adjunct to surgical intervention for the last five decades, in view of documented effect on local control and reduced rates of vaginal vault recurrences. As surgical staging became established as part of the initial approach, a reassessment of the role of radiation in well-staged patients with low and intermediate risks of recurrence is ongoing. Intracavitary brachytherapy has low morbidity and is often used to reduce vaginal vault recurrences. External beam radiotherapy, on the other hand, achieves local control at the cost of some morbidity, and its impact on survival is uncertain.

Keywords

Endometrial cancer Brachytherapy External beam 

References

  1. 1.
    Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M.J. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRefGoogle Scholar
  2. 2.
    Stander, R.W. Vaginal metastastases following treatment of endometrial carcinoma. Am J Obstet Gynecol. 1956;71:776–9.PubMedGoogle Scholar
  3. 3.
    Price, J.J., Hahn, G.A., Rominger, C.J. Vaginal Involvement in Endometrial Carcinoma. Am J Obstet Gynecol. 1965;91:1060–5.PubMedGoogle Scholar
  4. 4.
    Creutzberg, C.L., van Putten, W.l., Koper, P.C., Lybeert, M.L., Jobsen, J.J., Warlam-Rodenhuis, C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404–11.PubMedCrossRefGoogle Scholar
  5. 5.
    Keys, H.M., Roberts, J.A., Brunetto, V.L., Zaino, R.J., Spirtos, N.M., Bloss, J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51.PubMedCrossRefGoogle Scholar
  6. 6.
    Nag, S., Yacoub, S., Copeland, L.J., Fowler, J.M. Interstitial brachtherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2002;54:1153–9.CrossRefGoogle Scholar
  7. 7.
    Jereczek-Fossa, B., Badzio, A., Jassem, J. Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:405–13.PubMedCrossRefGoogle Scholar
  8. 8.
    Petignat, P., Jolocoeur, M., Alobaid, A., Drouin, P., Gauthier, P., Provencher, D., et al. Salvage treatment with high-dose-rate brachytherapy for isolated veginal endometrial cancer recurrence. Gynecol Oncol. 2006;101:445–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Huh, W.K., Straughn, J.M., Jr., Mariani, A., Podratz, K.C., Havrilesky, L.J., Alvarez-Secord, A., et al. Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gyenecol Cancer. 2007;17:886–9.CrossRefGoogle Scholar
  10. 10.
    Creasman, W.T., Morrow, C.P., Bundy, B.N., Homesley, H.D., Graham, J.E., Heller, P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035–41.PubMedCrossRefGoogle Scholar
  11. 11.
    Ben-Shacher, I., Pavelka, J., Cohn, D.E., Copeland, L.J., Ramirez, N., Manolotsas, T., et al. Surgical staging for patients presenting presenting with grade 1 endometrial carcinoma. Obstetrics and gynecology. 2005;105:487–93.CrossRefGoogle Scholar
  12. 12.
    Mariani, A., Webb, M.J., Keeney, G.L., Haddock, M.G., Calori, G., Podratz, K.C. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506–19.PubMedCrossRefGoogle Scholar
  13. 13.
    Creasman, W.T., DeGeest, K., DiSaia, P.J., Zaino, R.J. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1999;181:31–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Straughn, J.M., Jr., Huh, W.K., Kelly, F.J., Leath, C.A., 3rd, Kleinberg, M.J., Hyde, J., Jr., et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol. 2002;84:194–200.PubMedCrossRefGoogle Scholar
  15. 15.
    Shumsky, A.G., Brasher, P.M., Stuart, G.C., Nation, J.G. Risk-specific follow-up for endometrial carcinoma patients. Gynecol Oncol. 1997;65:379–82.PubMedCrossRefGoogle Scholar
  16. 16.
    DiSaia, P.J., Creasman, W.T., Boronow, R.C., Blessing, J.A. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985;151:1009–15.PubMedGoogle Scholar
  17. 17.
    Kilgore, L.C., Partidge, E.E., Alvarez, R.D., Austin, J.M., Shingleton, H.M., Noojin, F., 3rd, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvicnode sampling. Gynecol Oncol. 1995;56:29–33.PubMedCrossRefGoogle Scholar
  18. 18.
    Carey, M.S., O’Connell, G.J., Johansson, C.R., Goodyear, M.D., Murphy, K.J., Daya, D.M., et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 1995;57:138–44.PubMedCrossRefGoogle Scholar
  19. 19.
    Elliott, P., Green, D., Coates, A., Krieger, M., Russell, P., Coppleson, M., et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer. 1994;4:84–93.PubMedCrossRefGoogle Scholar
  20. 20.
    Straughn, I.M., Huh, W.K., Orr, J.W., Jr., Kell, F.J., Roland, P.Y., Gold, M.A., et al. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol. 2003;89:295–300.PubMedCrossRefGoogle Scholar
  21. 21.
    Lee, C.M., Szabo, A., Shrieve, D.C., Macdonald, O.K., Gaffney, D.K. Frequency and effect of adjuvant radiation therapy among women with stage | endometrial adenocarcinoma. Jama. 2006;295:389–97.PubMedCrossRefGoogle Scholar
  22. 22.
    Straughn, J.M., Jr., Numnum, T.M., Kilgore, L.C., Partridge, E.E., Phillips, J.L., Markman, M., et al. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base. Gynecol Oncol. 2005;99:530–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Macdonald, O.K., Sause, W.T., Lee, R.J., Lee, C.M., Dodson, M.K., Zempolich, K., et al. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecol Oncol. 2006;103:661–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Irwin, C., Levin, W., Fyles, A., Pintilie, M., Manchul, L., Kirkbride, P. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol. 1998;70:247–54.PubMedCrossRefGoogle Scholar
  25. 25.
    Greven, K.M., Corn, B.W., Case, D., Purser, P., Lanciano, R.M. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys. 1997;39:413–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Calvin, D.P., Connell, P.P., Rotmensch, J., Waggoner, S., Mundt, A.J. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999;22:338–43.PubMedCrossRefGoogle Scholar
  27. 27.
    Aalders, J., Abeler, V., Kolstad, P., Onsrud, M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstetrics and gynecology. 1980;56:419–27.PubMedGoogle Scholar
  28. 28.
    Piver, M.S., Hempling, R.E. A prospective trial of postoperative vaginal radium/cesium for grade 1–2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma. Cancer. 1990;66:1133–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Chadha, M., Nanavati, P.J., Liu, P., Fanning, J., Jacobs, A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol. 1999;75:103–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Chong, I.Y., Hoskin, P.J. Vaginal vault brachytherapy for low risk endometrial carcinoma. Clin Oncol (R Coll Radiol). 2007;19:S8.CrossRefGoogle Scholar
  31. 31.
    Eltabbakh, G.H., Piver, M.S., Hempling, R.E., Shin, K.H. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trail. Int J Radiat Oncol Biol Phys. 1997;38:373–80.PubMedCrossRefGoogle Scholar
  32. 32.
    Alektiar, K.M., Venkatraman, E., Chi, D.S., Barakat, R.R. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:111–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Pearcey, R.G., Petereit, D.G. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol. 2000;56:17–22.PubMedCrossRefGoogle Scholar
  34. 34.
    Orton, C.G. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys. 2001;49:183–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Fayed, A., Mutch, D.G., Rader, J.S., Gibb, R.K., Powell, M.A., Wright, J.D., et al. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2007;67:480–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Bekerus, M., Durbaba, M., Frim, O., Vujnic, V. comparison of HDR and LDR results in endometrium cancer. Sonderb Strahlenther Onkol. 1988;82:222–7.PubMedGoogle Scholar
  37. 37.
    Rauthe, G., Vahrson, H., Giers, G. Five-year results and complications in endometrium cancer: HDR afterloading vs. conventional radium therapy. Sonderb Strahlenther Onkol. 1988;82:240–5.PubMedGoogle Scholar
  38. 38.
    Small, W., Jr., Erickson, B., Kwakwa, F. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int J Radiat Oncol Biol Phys. 2005;63:1502–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Nag, S., Erickson, B., Thomadsen, B., Orton, C., Demanes, J.D., Petereit, D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–11.PubMedCrossRefGoogle Scholar
  40. 40.
    Houdek, P.V., Schwade, J.G., Abitbol, A.A., Pisciotta, V., Wu, X.D., Serago, C.F., et al. Optimization of high dose-rate cervix brachytherapy; Part I: Dose distribution. Int J Radiat Oncol Biol Phys. 1991;21:1621–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Maruyama, Y., Ezzell, G., Porter, A.T. Afterloading high dose rate intracavitary vaginal cylinder. Int J Radiat Oncol Biol Phys. 1994;30:473–6.PubMedGoogle Scholar
  42. 42.
    Demanes, D.J., Rege, S., Rodriquez, R.R., Schutz, K.L., Altieri, G.A., Wong, T. The use and advantages of a multichannel vaginal cyclinder in high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;44:211–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Corn, B.W., Lanciano, R.M., Greven, K.M., Noumoff, J., Schultz, D., Hanks, G.E., et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol. 1994;12:510–5.PubMedGoogle Scholar
  44. 44.
    Algan, O., Tabesh, T., Hanlon, A., Hogan, W.M., Boente, M., Lanciano, R.M. Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer. Int J Radiat Oncol Biol Phys. 1996;35:925–33.PubMedCrossRefGoogle Scholar
  45. 45.
    Creutzberg, C.L., van Putten, W.L., Koper, P.C., Lybeert, M.L., Jobsen, J.J., Warlam-Rodenhuis, C.C., et al. The morbidity of treatment for patients with Stage I endometrial cancer; results from a randomized trial. Int J Radiat Oncol Biol Phys. 2001;51:1246–55.PubMedCrossRefGoogle Scholar
  46. 46.
    Horowitz, N.S., Peters, W.A., 3rd, Smith, M.R., Drescher, C.W., Atwood, M., Mate, T.P. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endomentrial carcinoma. Obstetrics and gynecology. 2002;99:235–40.PubMedCrossRefGoogle Scholar
  47. 47.
    Alektiar, K.M., McKee, A., Venkatraman, E., Mckee, B., Zelefsky, M.J., Mychalczak, B.R., et al. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer. Int J Radiat Oncol Biol Phys. 2002;53:707–13.PubMedCrossRefGoogle Scholar
  48. 48.
    Petereit, D.G., Tannehill, S.P., Grosen, E.A., Hartenbach, E.M., Schink, J.C. Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gynecol Cancer. 1999;9:456–62.PubMedCrossRefGoogle Scholar
  49. 49.
    Sorbe, B.G., Smeds, A.C. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I. Int J Radiat Oncol Biol Phys. 1990;18:305–14.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Lea Baer
    • 1
    Email author
  • A. Gabriella Wernicke
    • 1
  • Silvia Formenti
    • 1
  1. 1.Department of Radiation Oncology, NYU Cancer Institute, NYU Medical CenterNew York

Personalised recommendations